Enforcement Rules of the Patent Act Article 17
When filing a patent application for invention, the description shall contain the following items:1. title of invention;2. technical field;3. prior art: indicate the prior art known to the applicant, where relevant materials reflect such art may be submitted;4. summary of invention: disclose the problem(s) that the invention aims to solve and its technical solution adopted to solve the problem(s); and state any advantageous effects of the invention with reference to the prior art;5. brief description of drawing(s): where the description is accompanied by drawing(s), description of the drawing(s) shall be made concisely according to the drawing sequence;6. description of embodiments: describe at least one way of carrying out the invention, use examples where appropriate, and refer to the drawing(s), if any; and7. reference signs list: where the description is accompanied by drawing(s), major reference signs of the drawing(s) shall be listed and illustrated according to the drawing sequence or reference signs sequence.The description shall be presented in the manner and order specified in each subparagraph of the preceding paragraph, and each of the parts shall be preceded by a heading; unless, owing to the nature of the invention, a different presentation would result in a better understanding.The paragraphs of the description may be arranged with four consecutive Arabic numbers in separate square brackets so that each of the paragraphs can be clearly identified.The title of invention should concisely state the contents of the claimed inventions; irrelevant wording is not allowed.When a patent application for invention involves a biological material or utilization of a biological material, where the biological material concerned has been deposited, the description shall specify the depository, date of deposit and deposit number. In the event that, prior to filing the patent application, the biological material concerned has been deposited in a foreign depository recognized by the Specific Patent Agency, the description shall also specify the foreign depository, date of deposit, and deposit number.Where a biological material is deposited in a depository as specified in Paragraph 5 Article 27 of the Act, the certificate issued by the aforementioned depository shall include a viability test report of the deposited biological material.Where a patent application for invention contains disclosure of one or more nucleotides and/or amino acids sequence, a sequence listing produced in compliance with the standard provided by the Specific Patent Agency shall be submitted as a separate part of the description. In addition, the said sequence listing may be submitted in the electronic version thereof in compliance with the requirement of the Specific Patent Agency.
中文原文 專利法施行細則第17條
申請發明專利者，其說明書應載明下列事項：
一、發明名稱。
二、技術領域。
三、先前技術：申請人所知之先前技術，並得檢送該先前技術之相關資料。
四、發明內容：發明所欲解決之問題、解決問題之技術手段及對照先前技術之功效。
五、圖式簡單說明：有圖式者，應以簡明之文字依圖式之圖號順序說明圖式。
六、實施方式：記載一個以上之實施方式，必要時得以實施例說明；有圖式者，應參照圖式加以說明。
七、符號說明：有圖式者，應依圖號或符號順序列出圖式之主要符號並加以說明。
說明書應依前項各款所定順序及方式撰寫，並附加標題。
但發明之性質以其他方式表達較為清楚者，不在此限。
說明書得於各段落前，以置於中括號內之連續四位數之阿拉伯數字編號依序排列，以明確識別每一段落。
發明名稱，應簡明表示所申請發明之內容，不得冠以無關之文字。
申請生物材料或利用生物材料之發明專利，其生物材料已寄存者，應於說明書載明寄存機構、寄存日期及寄存號碼。
申請前已於國外寄存機構寄存者，並應載明國外寄存機構、寄存日期及寄存號碼。
生物材料寄存於本法第二十七條第五項規定之寄存機構者，該寄存機構出具之證明文件，應具有該生物材料之存活證明。
發明專利包含一個或多個核苷酸或胺基酸序列者，說明書應包含依專利專責機關訂定之格式單獨記載之序列表。
其序列表得以專利專責機關規定之電子檔為之。
一、發明名稱。
二、技術領域。
三、先前技術：申請人所知之先前技術，並得檢送該先前技術之相關資料。
四、發明內容：發明所欲解決之問題、解決問題之技術手段及對照先前技術之功效。
五、圖式簡單說明：有圖式者，應以簡明之文字依圖式之圖號順序說明圖式。
六、實施方式：記載一個以上之實施方式，必要時得以實施例說明；有圖式者，應參照圖式加以說明。
七、符號說明：有圖式者，應依圖號或符號順序列出圖式之主要符號並加以說明。
說明書應依前項各款所定順序及方式撰寫，並附加標題。
但發明之性質以其他方式表達較為清楚者，不在此限。
說明書得於各段落前，以置於中括號內之連續四位數之阿拉伯數字編號依序排列，以明確識別每一段落。
發明名稱，應簡明表示所申請發明之內容，不得冠以無關之文字。
申請生物材料或利用生物材料之發明專利，其生物材料已寄存者，應於說明書載明寄存機構、寄存日期及寄存號碼。
申請前已於國外寄存機構寄存者，並應載明國外寄存機構、寄存日期及寄存號碼。
生物材料寄存於本法第二十七條第五項規定之寄存機構者，該寄存機構出具之證明文件，應具有該生物材料之存活證明。
發明專利包含一個或多個核苷酸或胺基酸序列者，說明書應包含依專利專責機關訂定之格式單獨記載之序列表。
其序列表得以專利專責機關規定之電子檔為之。